These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22115051)

  • 1. Targeting cholesterol-rich microdomains to circumvent tamoxifen-resistant breast cancer.
    Tiwary R; Yu W; deGraffenried LA; Sanders BG; Kline K
    Breast Cancer Res; 2011; 13(6):R120. PubMed ID: 22115051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of TMEM47 Induces Tamoxifen Resistance in Human Breast Cancer Cells.
    Men X; Su M; Ma J; Mou Y; Dai P; Chen C; Cheng XA
    Technol Cancer Res Treat; 2021; 20():15330338211004916. PubMed ID: 33745390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the CD59 Glycoprotein Precursor is Upregulated in an Estrogen Receptor-alpha (ER-α)-Negative and a Tamoxifen-Resistant Breast Cancer Cell Line In Vitro.
    Xiong H; Jin X; You C
    Med Sci Monit; 2018 Nov; 24():7883-7890. PubMed ID: 30391994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
    Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
    Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGR3 and estrone are involved in the tamoxifen resistance and progression of breast cancer.
    Xie Y; Han X; Yu J; Yuan M; Yan Y; Qin J; Lan L; Wang Y
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):18103-18117. PubMed ID: 37999751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells.
    Moon SY; Lee H; Kim S; Hong JH; Chun SH; Lee HY; Kang K; Kim HS; Won HS; Ko YH
    BMC Cancer; 2021 Aug; 21(1):931. PubMed ID: 34407787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global characterization of signalling networks associated with tamoxifen resistance in breast cancer.
    Browne BC; Hochgräfe F; Wu J; Millar EK; Barraclough J; Stone A; McCloy RA; Lee CS; Roberts C; Ali NA; Boulghourjian A; Schmich F; Linding R; Farrow L; Gee JM; Nicholson RI; O'Toole SA; Sutherland RL; Musgrove EA; Butt AJ; Daly RJ
    FEBS J; 2013 Nov; 280(21):5237-57. PubMed ID: 23876235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of PKC-ERK signaling in tamoxifen-induced apoptosis and tamoxifen resistance in human breast cancer cells.
    Li Z; Wang N; Fang J; Huang J; Tian F; Li C; Xie F
    Oncol Rep; 2012 Jun; 27(6):1879-86. PubMed ID: 22427054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-TEA cooperates with MEK or mTOR inhibitors to induce apoptosis via targeting IRS/PI3K pathways.
    Tiwary R; Yu W; Sanders BG; Kline K
    Br J Cancer; 2011 Jan; 104(1):101-9. PubMed ID: 21119656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PI3-kinase/p38 kinase-dependent E2F1 activation is critical for Pin1 induction in tamoxifen-resistant breast cancer cells.
    Lee KY; Lee JW; Nam HJ; Shim JH; Song Y; Kang KW
    Mol Cells; 2011 Jul; 32(1):107-11. PubMed ID: 21573702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lycorine weakens tamoxifen resistance of breast cancer via abrogating HAGLR-mediated epigenetic suppression on VGLL4 by DNMT1.
    Zhai J; Jiang JF; Shi L
    Kaohsiung J Med Sci; 2023 Mar; 39(3):278-289. PubMed ID: 36606584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keratinocyte growth factor (KGF) regulates estrogen receptor-alpha (ER-alpha) expression and cell apoptosis via phosphatidylinositol 3-kinase (PI3K)/Akt pathway in human breast cancer cells.
    Chang HL; Sugimoto Y; Liu S; Wang LS; Huang YW; Ye W; Lin YC
    Anticancer Res; 2009 Aug; 29(8):3195-205. PubMed ID: 19661335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new synthetic HDAC inhibitor, MHY218, induces apoptosis or autophagy-related cell death in tamoxifen-resistant MCF-7 breast cancer cells.
    Park JH; Ahn MY; Kim TH; Yoon S; Kang KW; Lee J; Moon HR; Jung JH; Chung HY; Kim HS
    Invest New Drugs; 2012 Oct; 30(5):1887-98. PubMed ID: 21983700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid lipid nanoparticles: Reversal of tamoxifen resistance in breast cancer.
    Guney Eskiler G; Cecener G; Dikmen G; Egeli U; Tunca B
    Eur J Pharm Sci; 2018 Jul; 120():73-88. PubMed ID: 29719240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of vitamin E on tamoxifen-treated breast cancer cells.
    Peralta EA; Viegas ML; Louis S; Engle DL; Dunnington GL
    Surgery; 2006 Oct; 140(4):607-14; discussion 614-5. PubMed ID: 17011908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen resistance induction results in the upregulation of ABCG2 expression and mitoxantrone resistance in MCF-7 breast cancer cells.
    Ghalehno AD; Abdi H; Boustan A; Jamialahmadi K; Mosaffa F
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Dec; 396(12):3723-3732. PubMed ID: 37310508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of BAG-1 expression alters the sensitivity of breast cancer cells to tamoxifen.
    Liu H; Lu S; Gu L; Gao Y; Wang T; Zhao J; Rao J; Chen J; Hao X; Tang SC
    Cell Physiol Biochem; 2014; 33(2):365-74. PubMed ID: 24557447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer.
    Loh YN; Hedditch EL; Baker LA; Jary E; Ward RL; Ford CE
    BMC Cancer; 2013 Apr; 13():174. PubMed ID: 23547709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone-tamoxifen combination exerts synergistic therapeutic effects in tamoxifen-resistance breast cancer cells.
    Gaballah AI; Elsherbiny AA; Sharaky M; Hamed NO; Raslan NA; Almilaibary A; Fayyad RMA; Ousman MS; Hamdan AME; Fahim SA
    Biosci Rep; 2024 Jul; 44(7):. PubMed ID: 38864530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer.
    Larsen SL; Yde CW; Laenkholm AV; Rasmussen BB; Duun-Henriksen AK; Bak M; Lykkesfeldt AE; Kirkegaard T
    BMC Cancer; 2015 Apr; 15():239. PubMed ID: 25885472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.